149 related articles for article (PubMed ID: 35736358)
1. [Overtreatment of patients with basal cell carcinoma: active surveillance should be considered more often].
Lubeek SFK; Schers HJ; Schoon Y; Kelleners-Smeets NWJ
Ned Tijdschr Geneeskd; 2022 May; 166():. PubMed ID: 35736358
[TBL] [Abstract][Full Text] [Related]
2. The therapeutic dilemma of basal cell carcinoma in older adults: A review of the current literature.
Van Coile L; Verhaeghe E; Ongenae K; Destrooper L; Mohamadi Z; Brochez L; Hoorens I
J Geriatr Oncol; 2023 Apr; 14(3):101475. PubMed ID: 36990928
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Watchful Waiting and Tumor Behavior in Patients With Basal Cell Carcinoma: An Observational Cohort Study of 280 Basal Cell Carcinomas in 89 Patients.
van Winden MEC; Hetterschijt CRM; Bronkhorst EM; van de Kerkhof PCM; de Jong EMGJ; Lubeek SFK
JAMA Dermatol; 2021 Oct; 157(10):1174-1181. PubMed ID: 34495284
[TBL] [Abstract][Full Text] [Related]
4. Risks of different skin tumour combinations after a first melanoma, squamous cell carcinoma and basal cell carcinoma in Dutch population-based cohorts: 1989-2009.
van der Leest RJT; Hollestein LM; Liu L; Nijsten T; de Vries E
J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):382-389. PubMed ID: 28898461
[TBL] [Abstract][Full Text] [Related]
5. Non-melanoma skin cancer: United Kingdom National Multidisciplinary Guidelines.
Newlands C; Currie R; Memon A; Whitaker S; Woolford T
J Laryngol Otol; 2016 May; 130(S2):S125-S132. PubMed ID: 27841126
[TBL] [Abstract][Full Text] [Related]
6. Common skin cancers in older adults: approach to diagnosis and management.
Council ML
Clin Geriatr Med; 2013 May; 29(2):361-72. PubMed ID: 23571033
[TBL] [Abstract][Full Text] [Related]
7. Basal cell carcinoma in older adults: how to decide when active surveillance or watchful waiting is appropriate?
Van Coile L; Verhaeghe E; Ongenae K; Brochez L; Hoorens I
Br J Dermatol; 2022 Aug; 187(2):244-245. PubMed ID: 35157305
[No Abstract] [Full Text] [Related]
8. Periocular skin cancer: Diagnosis and management.
Moran JM; Phelps PO
Dis Mon; 2020 Oct; 66(10):101046. PubMed ID: 32600650
[TBL] [Abstract][Full Text] [Related]
9. Topical and systemic medical treatments of basal cell carcinoma.
Sollena P; Del Regno L; Fargnoli MC; Peris K
G Ital Dermatol Venereol; 2015 Aug; 150(4):429-34. PubMed ID: 26086413
[TBL] [Abstract][Full Text] [Related]
10. Association of Age, Sex, Race, and Geographic Region With Variation of the Ratio of Basal Cell to Cutaneous Squamous Cell Carcinomas in the United States.
Lukowiak TM; Aizman L; Perz A; Miller CJ; Sobanko JF; Shin TM; Giordano CN; Higgins HW; Etzkorn JR
JAMA Dermatol; 2020 Nov; 156(11):1192-1198. PubMed ID: 32845319
[TBL] [Abstract][Full Text] [Related]
11. Non-melanoma Skin Cancer - a Clinicopathological Study of Patients with Basal Cell Carcinoma and Squamous Cell Carcinoma.
Bartoš V; Kullová M
Klin Onkol; 2017; 31(1):40-45. PubMed ID: 29488777
[TBL] [Abstract][Full Text] [Related]
12. What is your skin cancer IQ? Identifying BCC, SCC, and melanoma.
Oncology (Williston Park); 2007 May; 21(6):752. PubMed ID: 17564330
[No Abstract] [Full Text] [Related]
13. Premalignant lesions, basal cell carcinoma and melanoma in patients with cutaneous squamous cell carcinoma.
Korhonen N; Ylitalo L; Luukkaala T; Itkonen J; Häihälä H; Jernman J; Snellman E; Palve J
Arch Dermatol Res; 2021 Dec; 313(10):879-884. PubMed ID: 32772261
[TBL] [Abstract][Full Text] [Related]
14. Basal cell skin cancer and the risk of second primary cancers: a cancer registry-based study in Lithuania.
Krilaviciute A; Vincerzevskiene I; Smailyte G
Ann Epidemiol; 2016 Jul; 26(7):511-514. PubMed ID: 27262816
[TBL] [Abstract][Full Text] [Related]
15. Identifying patients at risk for recurrent or advanced BCC.
Hamid O; Goldenberg G
J Drugs Dermatol; 2013 Nov; 12(11):1246-52; quiz 1253-4. PubMed ID: 24196332
[TBL] [Abstract][Full Text] [Related]
16. A nationwide study of the incidence and trends of first and multiple basal cell carcinomas in the Netherlands and prediction of future incidence.
Schreuder K; Hollestein L; Nijsten TEC; Wakkee M; Louwman MWJ
Br J Dermatol; 2022 Mar; 186(3):476-484. PubMed ID: 34726263
[TBL] [Abstract][Full Text] [Related]
17. The occurrence of non-melanoma malignant skin lesions and non-cutaneous squamous-cell carcinoma among metastatic melanoma patients: an observational cohort study in Denmark.
Li H; Pedersen L; Nørgaard M; Ulrichsen SP; Thygesen SK; Nelson JJ
BMC Cancer; 2016 May; 16():295. PubMed ID: 27141983
[TBL] [Abstract][Full Text] [Related]
18. Association Between Health Maintenance Practices and Skin Cancer Risk as a Possible Source of Detection Bias.
Drucker AM; Li WQ; Savitz DA; Weinstock MA; Han J; Li T; Qureshi AA; Cho E
JAMA Dermatol; 2019 Mar; 155(3):353-357. PubMed ID: 30586131
[TBL] [Abstract][Full Text] [Related]
19. Basal cell carcinoma: pathogenesis, epidemiology, clinical features, diagnosis, histopathology, and management.
Marzuka AG; Book SE
Yale J Biol Med; 2015 Jun; 88(2):167-79. PubMed ID: 26029015
[TBL] [Abstract][Full Text] [Related]
20. [Malignant epithelial and melanocytic skin tumors].
Guillot B; Du-Thanh A
Rev Prat; 2012 Feb; 62(2):247-54. PubMed ID: 22408878
[No Abstract] [Full Text] [Related]
[Next] [New Search]
